Technology

More from the Series

Blog Post
It's Technology, Stupid: How Important is Innovation for Better Development Outcomes?
April 10, 2019
While income growth has been labeled "the holy grail of development," new analysis from Owen Barder, Lee Robinson, and Euan Ritchie suggests that there is just as much value in focusing on promoting innovation and the spread of technology.
Blog Post
Hustlers, Mavens, and Rainmakers: How the Informal are Inheriting Africa
Bright Simons
March 25, 2019
In Africa, as in much of the developing world, “informality” has become the dread of policymakers who are constantly told by international development agencies and consultants to “formalise” their economies.
Blog Post
Africa’s Unsung “Industrial Revolution”
Bright Simons
March 21, 2019
There is an industrial revolution underway in sub-Saharan Africa’s most entrepreneurial economies.
CGD NOTES
Why “Leapfrogging” in Frontier Markets Isn’t Working
Bright Simons
March 21, 2019
There are two big questions about modern innovation: Why does it tend to confine itself to only a narrow “vanguard” of the economy in every part of the world? And why does it not provide as big a boost to productivity as expected, especially since the dotcom bust?
Blog Post
Tom Standage on Sounds Robotic: A CGD Podcast
March 06, 2019
In this episode of Sounds Robotic, we discuss the potential upsides of AI and automation as well as the "lump of labor" fallacy as applied to robots.
Blog Post
Women Social Entrepreneurs and Tech Can Accelerate SDG 5 in India, the World’s Largest Democracy
Radhika Shah et al.
March 06, 2019
While there are several success stories where technology has helped level the playing field and brought economic opportunities to vulnerable communities in India, the question remains: Will technology help advance gender equality, or will it instead fuel a growing gender-digital divide?
Blog Post
Is Traceability Good Medicine for Dysfunctional Health Supply Chains?
February 25, 2019
In many developing countries health supply chains function poorly, resulting in frequent stockouts and many substandard and even falsified medications—which undermine treatment effectiveness and raise the risk of antimicrobial resistance.